Study on the Safety and Effects on Lipids of FM-VP4 in Subjects With Primary Hypercholesterolemia

Completed · Phase 2

Conditions studied: Hypercholesterolemia

In brief

The purpose of this study is to evaluate the safety and effects on lipids of FM-VP4 administered for 12 weeks in subjects with mild to moderate primary hypercholesterolemia.

Key facts

Study ID

NCT00293878

Run by

Forbes Medi-Tech

People needed

150

Starts

2005-11-01

Last updated by the study team

2007-02-26

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Mild to moderate primary hypercholesterolemia
• Able to give informed consent and to comply with study procedures (including diet)

You may not qualify if…

• Homozygous familial hypercholesterolemia
• Age <18 or >75 years
• Pregnant women or women of child-bearing potential

Where it is running

• Coastal Clinical Research — Mobile, Alabama, United States
• Radiant Research — San Diego, California, United States
• Radiant Research — Daytona Beach, Florida, United States
• Radiant Research — Gainesville, Florida, United States
• Radiant Research — Boise, Idaho, United States
• Radiant Research — Chicago, Illinois, United States
• Midwest Institute for Clinical Research — Indianapolis, Indiana, United States
• PRA International Pharmacology Center — Lenexa, Kansas, United States
• The Center for Pharmaceutical Research — Kansas City, Missouri, United States
• Radiant Research — Portland, Oregon, United States
• Coastal Carolina Research Center — Mt. Pleasant, South Carolina, United States
• Radiant Research — Austin, Texas, United States
• Research Across America — Dallas, Texas, United States
• Radiant Research — Dallas, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.